A life sciences company in New Haven, Connecticut that aims to develop and commercialize novel technology leveraging Next-Generation Sequencing (NGS).
3
Funding Rounds
$12.8m
Money raised
The company AtlasXomics Inc. has raised a total of $8m in funding over 3 rounds.